| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8757979 | European Journal of Internal Medicine | 2018 | 8 Pages |
Abstract
Age, obesity, comorbidities, smoking habits, nasal polyps, allergic poly-sensitization might reduce Omalizumab effectiveness independently to other asthma-influencing factors.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
B. Sposato, M. Scalese, M. Milanese, S. Masieri, C. Cavaliere, M. Latorre, N. Scichilone, A. Matucci, A. Vultaggio, A. Ricci, A. Cresti, P. Santus, A. Perrella, P.L. Paggiaro,